维普期刊资源整合服务平台（V6.5）

433篇 您的检索式：作者名="Scheen"

选中清除导出查看参考文献查看引证文献引用追踪共22页首页上一页第1页下一页末页 /22 跳转

	题名	作者	年代	出处	被引量
1	A first drug combination for the treatment of arterial hypertension with a calcium channel antagonist (amlodipine besylate) and an angiotensin receptor blocker (valsartan) : Exforge 显示文摘	Krzesinski JM Scheen AJ	2007	Rev Meal Liege2007，62，11：	1
2	Degradation of short-chain alkyl-and alkanolamines by TiO2-and Pt/TiO2-assisted photocatalysis 显示文摘	KLARE M SCHEEN J VOGELSANG K	2000	Chemosphere2000，41，：	1
3	The postprandial state and risk of cardiovascular disease显示文摘	Lefebvre PJ Scheen AJ	1998	Diabetes Med1998，15，4：	1
4	Prevention of type 2 diabetes mellitus through inhibition of the Renin - Anglotensin system 显示文摘	Scheen AJ	2004	Drugs2004，64，22：	1
5	Nonalcoholic steatohepatitis:association with obesity and insulin resistance,and influence of weight loss显示文摘	Luyckx FH Lefebvre PJ Scheen AJ	2000	Diabetes Metab2000，26，2：	1
6	Bariatric surgery in patients with type 2 diabetes:benefits,risks,indications and perspectives显示文摘	Scheen AJ De Flines J De Roover A	2009	Diabetes Metab2009，35，62：	1
7	Nonalcoholic steatohepatitis 显示文摘	Luyckx FH Scheen A J Lefebvre PJ	2003	Lancet2003，361，9367：	1
8	Oral antidiabetic agents:a guide to selection显示文摘	Scheen AJ Lefebvre PJ	1998	Drugs1998，55，：	1
9	A review of gliptins for 2014显示文摘	Scheen AJ	2015	Expert opinion on pharmacotherapy2015，16，1：	1
10	Use of cannabinoid CB1 receptor antagonists for the treatment of metabolic disorders显示文摘	Scheen A J Paquot N	2009	Best Pract Res Clin Endocrinol Metab2009，23，1：	1
11	Tolerability profile of metformin/glibenclamide combination tablets(Glucovanee):a new treatment for the management of type 2 diabetes mellitus显示文摘	DAVIDSON JA SCHEEN AJ HOWLETT HC	2004	Drug Saf2004，27，15：	1
12	Efficacy and safety of saxagliptin in combination with metformin compared with sitagliptin in combination with mefformin in adult patients with type 2 diabetes mellitus显示文摘	Scheen AJ Charpentier G Ostgren C J		0，，07：	1
13	Metformin + saxagliptin for type 2 diabetes显示文摘	André J Scheen	2011	Expert Opinion on Pharmacotherapy2011，，1：	1
14	Effect of rimonabant, on blood pressure in overweight/obese patients with/without comorbidities: analysis of pooled RIO study results 显示文摘	Ruilope LM Despres JP Scheen A	2008	J Hypertens2008，26，2：	1
15	Oral anti diabetic agents:a guide to selection显示文摘	Lefebvere PJ	1998	Drugs1998，55，2：	1
16	Effect of rimonabant on blood pressure in overweight/obese patients with/without co-morbidities:analysis of pooled RIO study results显示文摘	Ruilope LM Despres JP Scheen A	2008	J nypertens2008，26，2：	1
17	The postprandial state and rish of cardiovascular disease 显示文摘	Lefebvre PJ Scheen AJ	1998	Diabet Med1998，15，64：	1
18	Changes in glucose turnover pa- rameters and improvement of glucose oxidation after 4 week magne- sium administration in eldly non-insulin-dependent(type 2) diabetic pa- tients 显示文摘	Paolisso G Scheen A Cozzolino D	1994	Journal of Clinical Endocrinology and Metabolism1994，，78：	1
19	Efficacy and tolerability of rimonabant in overweight or obese patients with type 2 diabetes: a randomised controlled study 显示文摘	Scheen AJ Finer N Hollander P	2006	Lancet2006，368，9548：	1
20	CBI receptor blockade and its impact on cardiometabolic risk factors: overview of the RIO programme with rimonabant 显示文摘	Scheen AJ	2008	J Neuroendocrinol2008，20，1：	1

返回顶部每页显示：

共22页首页上一页第1页下一页末页 /22 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示